Names including Kohls, Plug Power, and Mara Holdings round out the list of the market's top 10 most-shorted stocks.

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

The field of biotechnology has made significant strides in enhancing agricultural productivity by developing crops that can ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary 2025 lecture is titled “A CRISPR approach to neurodegenerative diseases.” ...

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $51.19, demonstrating a -1.88% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.79%.

CRISPR Therapeutics has burned $307 million in cash over the past year. With no long-term debt and $1.85 billion in cash left, the company could theoretically operate for years without raising ...